Literature DB >> 12869785

Scientific hazards of human reproductive 'cloning'.

Lorraine E Young1.   

Abstract

The scientific and clinical professional societies and associations covering the remit of Human Fertility are unanimously opposed to human reproductive 'cloning'. This article describes the main scientific objections to human reproductive 'cloning'. Data collected from numerous studies in a range of animal species indicate a high incidence of fetal defects, a stillbirth rate typically of more than 90% and a lack of adequate information on postnatal development. These concerns are exacerbated by misconceptions about the current ability to screen preimplantation embryos for 'cloning-induced' defects. Scientists and clinicians are sometimes treated with mistrust in the eyes of the public and media over such issues, perhaps because scientific information is not as well communicated as it might be. The duty of reproductive specialists is to convey the limits of their knowledge on this issue to the public and policymakers.

Entities:  

Mesh:

Year:  2003        PMID: 12869785     DOI: 10.1080/1464770312331369053

Source DB:  PubMed          Journal:  Hum Fertil (Camb)        ISSN: 1464-7273            Impact factor:   2.767


  3 in total

1.  Gene expression of Dnmt1 isoforms in porcine oocytes, embryos, and somatic cells.

Authors:  Angelica M Giraldo; Kristi DeCourcy; Suyapa F Ball; Darin Hylan; David L Ayares
Journal:  Cell Reprogram       Date:  2013-06-28       Impact factor: 1.987

2.  The effect of interspecific oocytes on demethylation of sperm DNA.

Authors:  Nathalie Beaujean; Jane E Taylor; Michelle McGarry; John O Gardner; Ian Wilmut; Pasqualino Loi; Grazyna Ptak; Cesare Galli; Giovanna Lazzari; Adrian Bird; Lorraine E Young; Richard R Meehan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

3.  Improves the In Vitro Developmental Competence and Reprogramming Efficiency of Cloned Bovine Embryos by Additional Complimentary Cytoplasm.

Authors:  Lianguang Xu; Ayman Mesalam; Kyeong-Lim Lee; Seok-Hwan Song; Imran Khan; M M R Chowdhury; Wenfa Lv; Il-Keun Kong
Journal:  Cell Reprogram       Date:  2019-02       Impact factor: 1.987

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.